Skip to content

Cooper

Pharma·UK·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Cooper?

Cooper is a British Pharma company, currently owned by CVC Capital Partners since 2021. It changed hands in 2021, when Charterhouse Capital Partners sold.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
CVC Capital Partners
Most recent investor
CVC Capital Partners
CVC Capital Partners Fund VII · 2017 · Buyout
2 ownership periods · full history below

Key facts

HQUK
SectorPharma
Key takeaways
  • ·Held by CVC Capital Partners since 2021 (5Y hold).
  • ·Best return: 3.0x MOIC by Charterhouse Capital Partners (2021 exit).

Ownership history

2 ownership periods

Active
Currently held by CVC Capital Partners since 2021.
Charterhouse Capital Partners
2015 · 2021(6yr) · Charterhouse Capital Partners X · 2016 · Buyout
Secondary · to CVC Capital Partners

Charterhouse Capital Partners sold Cooper to CVC Capital Partners in 2021 after 6 years.

MOIC
3.0x
CVC Capital Partners
2021 · present(5yr) · CVC Capital Partners Fund VII · 2017 · Buyout

Questions

Who owns Cooper?

Cooper is currently owned by CVC Capital Partners, through CVC Capital Partners Fund VII, since 2021.

When did CVC Capital Partners acquire Cooper?

CVC Capital Partners acquired Cooper in 2021.

Who did Cooper sell to?

Charterhouse Capital Partners sold Cooper to CVC Capital Partners in 2021 (Secondary), 3.0x return.

Who has owned Cooper over time?

Cooper has been through 2 private-equity ownership periods: Charterhouse Capital Partners · via Charterhouse Capital Partners X · 2015–2021 · sold to CVC Capital Partners · (Secondary) · 3.0x; CVC Capital Partners · via CVC Capital Partners Fund VII · since 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue